Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Desidustat

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 19,850Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zydus and ICMR Start Phase 2 Trial of Desidustat for Sickle Cell
    Zydus and ICMR Start Phase 2 Trial of Desidustat for Sickle Cell

    15 Oct 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/zydus-and-icmr-initiate-a-phase-2-trial-of-desidustat-in-patients-with-sickle-cell-disease-16318

    INDPHARMAPOST
    15 Oct 2024
    Share Share
    Zydus gets DCGI nod for drug to treat anaemia linked with kidney disease
    Zydus gets DCGI nod for drug to treat anaemia linked with kidney disease

    07 Mar 2022

    // BUSINESS-STANDARD

    https://www.business-standard.com/article/companies/zydus-gets-dcgi-nod-for-drug-to-treat-anaemia-linked-with-kidney-disease-122030700301_1.html

    BUSINESS-STANDARD
    07 Mar 2022
    Share Share
    SEC recommends permission to Zydus Cadila’s Desidustat subject to conditions
    SEC recommends permission to Zydus Cadila’s Desidustat subject to conditions

    20 Jan 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=145324&sid=1

    PHARMABIZ
    20 Jan 2022
    Share Share
    Zydus' Desidustat shows efficacy and safety in treating Hypoxia in COVID-19
    Zydus' Desidustat shows efficacy and safety in treating Hypoxia in COVID-19

    25 Jan 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/zydus-desidustat-shows-efficacy-and-safety-in-treating-hypoxia-in-hospitalized-covid-19-patients-in-mexico/

    BIOSPACE
    25 Jan 2021
    Share Share
    Zydus receives USFDA approval to initiate trials of Desidustat in Chemotherapy
    Zydus receives USFDA approval to initiate trials of Desidustat in Chemotherapy

    23 Jul 2020

    // BUSINESS-STANDARD

    https://www.business-standard.com/article/news-cm/zydus-receives-usfda-approval-to-initiate-trials-of-desidustat-in-chemotherapy-induced-anemia-120072300339_1.html#:~:text=Zydus%20announced%20that%20it%20has,Chemotherapy%20Induced%20Anemia%20(CIA).&text=Desidustat%20is%20expected%20to%20increase,the%20cancer%20patients%20with%20CIA.

    BUSINESS-STANDARD
    23 Jul 2020
    Share Share
    Zydus Cadila receives Mexican regulatory approval to test COVID-19, desidustat
    Zydus Cadila receives Mexican regulatory approval to test COVID-19, desidustat

    06 Jul 2020

    // PHARMABIZ

    http://pharmabiz.com/NewsDetails.aspx?aid=129399&sid=2

    PHARMABIZ
    06 Jul 2020
    Share Share